Antibody response to Brucella ovis outer membrane proteins in ovine brucellosis. 1990

J I Riezu-Boj, and I Moriyón, and J M Blasco, and C Gamazo, and R Díaz
Departamento de Microbiología, Universidad de Navarra, Pamplona, Spain.

Hot saline extracts of Brucella ovis were composed of vesicles with outer membrane proteins (OMPs), lipopolysaccharide, and phospholipid as constituents. Extraction with petroleum ether-chloroform-phenol yielded a protein fraction free of detectable lipopolysaccharide, in which group 3 OMPs (28,500 apparent molecular weight [28.5K], 27.0K, and 25.5K) represented 81% of the total. Group 1 OMPs and 67.0K, 22.5K to 21.5K, and 19.5K to 18.0K proteins were also detected. Adsorption of immune sera with whole bacteria suggested that group 3 OMPs and 67.0K, 22.5K to 21.5K, and 19.5K to 18.0K proteins had antigenic determinants exposed on the surfaces of both B. ovis and rough B. melitensis cells but not on smooth B. melitensis cells. Antibodies to group 3 OMPs and the 67.0K protein in the sera of 93 and 87%, respectively, of B. ovis-infected rams were found by immunoblotting. Antibodies to other proteins were present in 67% of these animals. Compared with B. ovis-infected rams which had not developed lesions, rams with epididymo-orchitis had antibodies to a larger variety of proteins. Although ewes infected with B. melitensis also showed antibodies to OMPs, the immunoblot reactions were less intense.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008297 Male Males
D002002 Brucella A genus of gram-negative, aerobic bacteria that causes BRUCELLOSIS. Its cells are nonmotile coccobacilli and are animal parasites and pathogens. The bacterium is transmissible to humans through contact with infected dairy products or tissue.
D002006 Brucellosis Infection caused by bacteria of the genus BRUCELLA mainly involving the MONONUCLEAR PHAGOCYTE SYSTEM. This condition is characterized by fever, weakness, malaise, and weight loss. Malta Fever,Undulant Fever,Brucella Infection,Brucellosis, Pulmonary,Cyprus Fever,Gibraltar Fever,Rock Fever,Brucella Infections,Brucelloses,Brucelloses, Pulmonary,Fever, Cyprus,Fever, Gibraltar,Fever, Malta,Fever, Rock,Fever, Undulant,Infection, Brucella,Pulmonary Brucelloses,Pulmonary Brucellosis
D005260 Female Females
D000327 Adsorption The adhesion of gases, liquids, or dissolved solids onto a surface. It includes adsorptive phenomena of bacteria and viruses onto surfaces as well. ABSORPTION into the substance may follow but not necessarily. Adsorptions
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D001425 Bacterial Outer Membrane Proteins Proteins isolated from the outer membrane of Gram-negative bacteria. OMP Proteins,Outer Membrane Proteins, Bacterial,Outer Membrane Lipoproteins, Bacterial
D012756 Sheep Any of the ruminant mammals with curved horns in the genus Ovis, family Bovidae. They possess lachrymal grooves and interdigital glands, which are absent in GOATS. Ovis,Sheep, Dall,Dall Sheep,Ovis dalli

Related Publications

J I Riezu-Boj, and I Moriyón, and J M Blasco, and C Gamazo, and R Díaz
December 1993, Journal of medical microbiology,
J I Riezu-Boj, and I Moriyón, and J M Blasco, and C Gamazo, and R Díaz
November 1987, Journal of clinical microbiology,
J I Riezu-Boj, and I Moriyón, and J M Blasco, and C Gamazo, and R Díaz
December 1992, Journal of clinical microbiology,
J I Riezu-Boj, and I Moriyón, and J M Blasco, and C Gamazo, and R Díaz
January 2007, Journal of immunoassay & immunochemistry,
J I Riezu-Boj, and I Moriyón, and J M Blasco, and C Gamazo, and R Díaz
January 2023, Frontiers in cellular and infection microbiology,
J I Riezu-Boj, and I Moriyón, and J M Blasco, and C Gamazo, and R Díaz
January 1987, Annales de l'Institut Pasteur. Microbiology,
J I Riezu-Boj, and I Moriyón, and J M Blasco, and C Gamazo, and R Díaz
March 2006, Vaccine,
J I Riezu-Boj, and I Moriyón, and J M Blasco, and C Gamazo, and R Díaz
August 1988, Theriogenology,
J I Riezu-Boj, and I Moriyón, and J M Blasco, and C Gamazo, and R Díaz
June 2021, Biochemical and biophysical research communications,
J I Riezu-Boj, and I Moriyón, and J M Blasco, and C Gamazo, and R Díaz
May 2021, Archives of microbiology,
Copied contents to your clipboard!